Amylin Pharmaceuticals to Webcast First Quarter Results and Morgan Stanley Global Healthcare Unplugged Conference Presentation
April 29 2005 - 6:42PM
PR Newswire (US)
Amylin Pharmaceuticals to Webcast First Quarter Results and Morgan
Stanley Global Healthcare Unplugged Conference Presentation SAN
DIEGO, April 29 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals,
Inc. (NASDAQ:AMLN) will webcast its Quarterly Update Conference
Call for the first quarter of 2005 on Wednesday, May 4, 2005 at
12:00 p.m. ET/9:00 a.m. PT. The call will be led by Ginger L.
Graham, Amylin's President and Chief Executive Officer. On the same
date, prior to the market open, Amylin will release financial
results for the first quarter ended March 31, 2004. For those
without access to the Internet, the live call may be accessed by
phone by calling (888) 396-2298 (domestic) or (617) 847-8708
(international), passcode 24262146. A replay of the Quarterly
Update Conference Call will also be available by phone for 24 hours
beginning approximately one hour after the close of the call and
can be accessed at (888) 286-8010 (domestic) or (617) 801-6888
(international), passcode 40550012. Amylin will also be presenting
at the Morgan Stanley Global Healthcare Unplugged Conference on
Thursday, May 5, 2005 at 11:15 a.m. ET/8:15 a.m. PT in Miami.
Daniel M. Bradbury, Chief Operating Officer of Amylin
Pharmaceuticals, will be providing a corporate overview. Both
events will be webcast live, and recordings will be made available.
The webcasts and recordings will be accessible through Amylin's
corporate website, located at http://www.amylin.com/. To access the
live webcasts, please log on to Amylin's site approximately fifteen
minutes prior to the events to register and download any necessary
audio software. Amylin Pharmaceuticals is a biopharmaceutical
company committed to improving lives through the discovery,
development and commercialization of innovative medicines.
DATASOURCE: Amylin Pharmaceuticals, Inc. CONTACT: Alice Bahner,
Executive Director, Investor Relations of Amylin Pharmaceuticals,
Inc., +1-858-552-2200, ext. 7272 Web site: http://www.amylin.com/
Copyright
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jul 2023 to Jul 2024